Should transfusions be administered to patients with abnormal transcranial Doppler (TCD) results and sickle cell disease (SCD)?

Updated: May 12, 2021
  • Author: Joseph E Maakaron, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The Stroke Prevention in Sickle Cell Anemia (STOP) trial demonstrated that a transfusion program in patients with abnormal TCD results normalizes the TCD results and reduces the risk of strokes. [51] A subsequent trial (STOPII) showed that when transfusions are discontinued, an unacceptably high percentage of patients show TCD reversion to high risk, and some suffer actual strokes. [52] On the other hand, TCD results normalize over time in some patients who do not receive transfusions.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!